September 2021: Aducanumab for Alzheimer's, antibiotics, shared-decision making, and dental health

September 2021: Aducanumab for Alzheimer's, antibiotics, shared-decision making, and dental health

BMJ talk medicine

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the September issue of DTB. They discuss the US FDA's controversial decision to license aducanumab for Alzheimer…

Related tracks

See all